Abstract
Background
Heart failure (HF) is an increasingly common condition affecting patients’ health-related quality of life (HRQL). However, there is little literature comparing HF-specific instruments. Our aim was to evaluate and compare data on the conceptual model and metric properties (reliability, validity and responsiveness) of HF-specific HRQL instruments, by performing a systematic review with meta-analyses.
Methods and results
Of 2,541 articles initially identified, 421 were full-text reviewed. Ninety-four reported data on five questionnaires: Minnesota Living with Heart Failure Questionnaire (MLHFQ), Chronic Heart Failure Questionnaire (CHFQ), Quality of Life Questionnaire for Severe Heart Failure (QLQ-SHF), Kansas City Cardiomyopathy Questionnaire (KCCQ) and Left Ventricular Dysfunction (LVD-36) questionnaire. Metric properties (reliability, validity and responsiveness) were summarised using meta-analysis for pools above five estimates. Cronbach’s alpha coefficients were generally high (0.83–0.95) for overall scores and scales measuring physical health. Associations with four validity criteria (New York Heart Association [NYHA] class, six-minute walk test [6MWT] and short form-36 [SF-36] ‘Physical’ and ‘Social Functioning’) were moderate to strong (0.41–0.84), except for those between two CHFQ domains (fatigue and dyspnoea) and the NYHA (0.19 and 0.22). Pooled estimates of change from eight meta-analyses showed the MLHFQ to be highly responsive, with changes in overall score ranging from −9.6 (95% confidence interval [CI]: −4.1; −15.2) for placebo to −17.7 (95% CI: −15.3; −20.2) for pacing devices. The CHFQ and KCCQ also showed good sensitivity to change.
Conclusions
Most of the questionnaires studied met minimum psychometric criteria, though current evidence would primarily support the use of the MLHFQ, followed by the KCCQ and CHFQ.
Similar content being viewed by others
Abbreviations
- ACEI:
-
Angiotensin-converting enzyme inhibitor
- CHFQ:
-
Chronic Heart Failure Questionnaire
- ES:
-
Effect size
- HRQL:
-
Health-related quality of life
- HF:
-
Heart failure
- ICC:
-
Intra-class correlation coefficient
- KCCQ:
-
Kansas City Cardiomyopathy Questionnaire
- LVD-36:
-
Left Ventricular Dysfunction-36 questionnaire
- MLHFQ:
-
Minnesota Living with Heart Failure Questionnaire
- NYHA:
-
New York Heart Association
- QLQ-SHF:
-
Quality of Life Questionnaire for Severe Heart Failure
- 6MWT:
-
Six-minute walk test
References
McMurray, J. J., & Pfeffer, M. A. (2005). Heart failure. Lancet, 365(9474), 1877–1889. doi:10.1016/S0140-6736(05)66621-4.
Bennet, S. J., Oldridge, N. B., Eckert, G. J., Embree, J. L., Browning, S., Hou, N., et al. (2002). Discriminant properties of commonly used quality of life measures in heart failure. Quality of Life Research, 11(4), 349–359. doi:10.1023/A:1015547713061.
Stewart, A. L., Greenfield, S., Hays, R. D., Wells, K., Rogers, W. H., Berry, S. D., et al. (1989). Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. Journal of the American Medical Association, 262(7), 907–913. doi:10.1001/jama.262.7.907.
Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Jr., Aaronson, N. K., Mosconi, P., et al. (2004). Health-related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project. Quality of Life Research, 13, 283–298. doi:10.1023/B:QURE.0000018472.46236.05.
Patrick, D. L., & Deyo, R. A. (1989). Generic and disease-specific measures in assessing health status and quality of life. Medical Care, 27(3 Suppl), S217–S232. doi:10.1097/00005650-198903001-00018.
Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine, 118(8), 622–629.
Guyatt, G. H. (1993). Measurement of health-related quality of life in heart failure. Journal of the American College of Cardiology, 22(4 Suppl A), 185A–191A.
Scientific Advisory Committee of the Medical Outcomes Trust. (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11(3), 193–205. doi:10.1023/A:1015291021312.
Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16(3), 297–334. doi:10.1007/BF02310555.
Prieto, L., Lamarca, R., & Casado, A. (1998). La evaluación de la fiabilidad en las observaciones clínicas: El coeficiente de correlación intraclase. Medicina Clínica, 110(4), 142–145.
Bulpitt, C. J., & Fletcher, A. (1991). Quality of life measures in cardiological disease. European Society of Cardiology, 10, 3–6.
Aaronson, N. K., Acquadro, C., Alonso, J., Apolone, G., Bucquet, D., Bullinger, M., et al. (1992). International Quality of Life Assessment (IQOLA) Project. Quality of Life Research, 1(5), 349–351. doi:10.1007/BF00434949.
Rossi, G. (1967). Nomenclature and diagnostic criteria in cardiology set by the New York Heart Association. Considerations on the 6th edition. Cuore e Circolazione, 51(6), 287–293.
Demers, C., McKelvie, R. S., Negassa, A., & Yusuf, S. (2001). Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. American Heart Journal, 142(4), 698–703. doi:10.1067/mhj.2001.118468.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale, New Jersey: Lawrence Erlbaum Associates.
Bonnet, D. G. (2002). Sample size requirements for testing and estimating coefficient alpha. Journal of Educational and Behavioral Statistics, 27(4), 335–340. doi:10.3102/10769986027004335.
Deeks, J., Higgins, J., Altman, D., & Cochrane Statistical Methods Group (2002). Review Manager Guide. Analysing and presenting results. In The Cochrane Library. Chichester: Wiley.
Delgado Rodriguez, M., Sillero Arenas, M., & Gálvez Vargas, R. (1991). [Meta-analysis in epidemiology (1): The general characteristics] Metaanalisis en epidemiologia (primera parte): Caracteristicas generales. Gaceta Sanitaria, 5, 265–272.
Artinian, N. T., Harden, J. K., Kronenberg, M. W., Vander Wal, J. S., Daher, E., Stephens, Q., et al. (2003). Pilot study of a Web-based compliance monitoring device for patients with congestive heart failure. Heart and Lung, 32(4), 226–233. doi:10.1016/S0147-9563(03)00026-8.
Atienza, F., Anguita, M., Martinez-Alzamora, N., Osca, J., Ojeda, S., Almenar, L., et al. (2004). Multicenter randomized trial of a comprehensive hospital discharge and outpatient heart failure management program. European Journal of Heart Failure, 6(5), 643–652.
Auricchio, A., Stellbrink, C., Butter, C., Sack, S., Vogt, J., Misier, A. R., et al. (2003). Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. Journal of the American College of Cardiology, 42(12), 2109–2116. doi:10.1016/j.jacc.2003.04.003.
Austin, J., Williams, R., Ross, L., Moseley, L., & Hutchison, S. (2005). Randomised controlled trial of cardiac rehabilitation in elderly patients with heart failure. European Journal of Heart Failure, 7(3), 411–417. doi:10.1016/j.ejheart.2004.10.004.
Baker, C. M., Christopher, T. J., Smith, P. F., Langberg, J. J., Delurgio, D. B., & Leon, A. R. (2002). Addition of a left ventricular lead to conventional pacing systems in patients with congestive heart failure: Feasibility, safety, and early results in 60 consecutive patients. Pacing and Clinical Electrophysiology, 25(8), 1166–1171. doi:10.1046/j.1460-9592.2002.01166.x.
Belardinelli, R., Georgiou, D., Cianci, G., & Purcaro, A. (1999). Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: Effects on functional capacity, quality of life, and clinical outcome. Circulation, 99(9), 1173–1182.
Benatar, D., Bondmass, M., Ghitelman, J., & Avitall, B. (2003). Outcomes of chronic heart failure. Archives of Internal Medicine, 163(3), 347–352. doi:10.1001/archinte.163.3.347.
Bennett, S. J., Baker, S. L., & Huster, G. A. (1998). Quality of life in women with heart failure. Health Care for Women International, 19(3), 217–229. doi:10.1080/073993398246386.
Bennett, S. J., Perkins, S. M., Lane, K. A., Deer, M., Brater, D. C., & Murray, M. D. (2001). Social support and health-related quality of life in chronic heart failure patients. Quality of Life Research, 10(8), 671–682. doi:10.1023/A:1013815825500.
Bouvy, M. L., Heerdink, E. R., Urquhart, J., Grobbee, D. E., Hoe, A. W., & Leufkens, H. G. (2003). Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: A randomized controlled study. Journal of Cardiac Failure, 9(5), 404–411. doi:10.1054/S1071-9164(03)00130-1.
Braunschweig, F., Linde, C., Gadler, F., & Rydén, L. (2000). Reduction of hospital days by biventricular pacing. European Journal of Heart Failure, 2(4), 399–406. doi:10.1016/S1388-9842(00)00113-6.
Briançon, S., Alla, F., Méjat, E., Guillemin, F., Villemot, J. P., Mertes, P. M., et al. (1997). Measurement of functional inability and quality of life in cardiac failure. Transcultural adaptation and validation of the Goldman, Minnesota and Duke questionnaires. Archives des Maladies du Coeur et des Vaisseaux, 90(12), 1577–1585.
Cazeau, S., Leclercq, C., Lavergne, T., Walker, S., Varma, C., Linde, C., et al. (2001). Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. The New England Journal of Medicine, 344(12), 873–880. doi:10.1056/NEJM200103223441202.
Chang, B. H., Hendricks, A., Zhao, Y., Rothendler, J. A., LoCastro, J. S., & Slawsky, M. T. (2005). A relaxation response randomized trial on patients with chronic heart failure. Journal of Cardiopulmonary Rehabilitation, 25(3), 149–157. doi:10.1097/00008483-200505000-00005.
Curiati, J. A., Bocchi, E., Freire, J. O., Arantes, A. C., Braga, M., Garcia, Y., et al. (2005). Meditation reduces sympathetic activation and improves the quality of life in elderly patients with optimally treated heart failure: A prospective randomized study. Journal of Alternative and Complementary Medicine (New York, N.Y.), 11(3), 465–472. doi:10.1089/acm.2005.11.465.
Cowley, A. J., Wiens, B. L., Segal, R., Rich, M. W., Santanello, N. C., Dasbach, E. J., et al. (2000). Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: The losartan heart failure ELITE quality of life substudy. Quality of Life Research, 9(4), 377–384. doi:10.1023/A:1008948930206.
Dall’Ago, P., Chiappa, G. R., Guths, H., Stein, R., & Ribeiro, J. P. (2006). Inspiratory muscle training in patients with heart failure and inspiratory muscle weakness: A randomized trial. Journal of the American College of Cardiology, 47(4), 757–763. doi:10.1016/j.jacc.2005.09.052. Epub 2006 Jan 26.
de Vries, R. J., Queré, M., Lok, D. J., Sijbring, P., Bucx, J. J., van Veldhuisen, D. J., et al. (1995). Comparison of effects on peak oxygen consumption, quality of life, and neurohormones of felodipine and enalapril in patients with congestive heart failure. The American Journal of Cardiology, 76(17), 1253–1258. doi:10.1016/S0002-9149(99)80352-X.
Delgado, D. H., Costigan, J., Wu, R., & Ross, H. J. (2003). An interactive Internet site for the management of patients with congestive heart failure. The Canadian Journal of Cardiology, 19(12), 1381–1385.
Di Lenarda, A., Sabbadini, G., Salvatore, L., Sinagra, G., Mestroni, L., Pinamonti, B., et al. (1999). Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group. Journal of the American College of Cardiology, 33(7), 1926–1934. doi:10.1016/S0735-1097(99)00134-5.
Doughty, R. N., Wright, S. P., Pearl, A., Walsh, H. J., Muncaster, S., Whalley, G. A., et al. (2002). Randomized, controlled trial of integrated heart failure management. The Auckland Heart Failure Management Study. European Heart Journal, 23(2), 139–146. doi:10.1053/euhj.2001.2712.
Edes, I., Gasior, Z., & Wita, K. (2005). Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: Results of the ENECA study. European Journal of Heart Failure, 7(4), 631–639. doi:10.1016/j.ejheart.2004.10.015.
Fung, J. W., Chan, S. K., Yeung, L. Y., & Sanderson, J. E. (2002). Is beta-blockade useful in heart failure patients with atrial fibrillation? An analysis of data from two previously completed prospective trials. European Journal of Heart Failure, 4(4), 489–494. doi:10.1016/S1388-9842(02)00031-4.
González-Juanatey, J. R., Alegría Ezquerra, E., García Saavedra, V., Pérez Ojeda, G., Ruiz Ros, J. A., Espinosa Caliani, J. S., et al. (2003). Use of bisoprolol in heart failure. The BISOCOR observational study. Revista Espanola de Cardiologia, 56(9), 873–879. doi:10.1157/13051614.
Gorkin, L., Norvell, N. K., Rosen, R. C., Charles, E., Shumaker, S. A., McIntyre, K. M., et al. (1993). Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy. The American Journal of Cardiology, 71(12), 1069–1073. doi:10.1016/0002-9149(93)90575-W.
Gottlieb, S. S., Fisher, M. L., Freudenberger, R., Robinson, S., Zietowski, G., Alves, L., et al. (1999). Effects of exercise training on peak performance and quality of life in congestive heart failure patients. Journal of Cardiac Failure, 5(3), 188–194. doi:10.1016/S1071-9164(99)90002-7.
Gras, D., Leclercq, C., Tang, A. S., Bucknall, C., Luttikhuis, H. O., & Kirstein-Pedersen, A. (2002). Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study. European Journal of Heart Failure, 4(3), 311–320. doi:10.1016/S1388-9842(02)00018-1.
Green, C. P., Porter, C. B., Bresnahan, D. R., & Spertus, J. A. (2000). Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: A new health status measure for heart failure. Journal of the American College of Cardiology, 35(5), 1245–1255. doi:10.1016/S0735-1097(00)00531-3.
Grigioni, F., Carigi, S., Grandi, S., Potena, L., Coccolo, F., Bacchi-Reggiani, L., et al. (2003). Distance between patients’ subjective perceptions and objectively evaluated disease severity in chronic heart failure. Psychotherapy and Psychosomatics, 72(3), 166–170. doi:10.1159/000069734.
Gundersen, T., Wiklund, I., Swedberg, K., Amtorp, O., Remes, J., & Nilsson, B. (1995). Effects of 12 weeks of ramipril treatment on the quality of life in patients with moderate congestive heart failure: Results of a placebo-controlled trial. Ramipril Study Group. Cardiovascular Drugs and Therapy, 9(4), 589–594. doi:10.1007/BF00878091.
Guyatt, G. H., Nogradi, S., Halcrow, S., Singer, J., Sullivan, M. J., & Fallen, E. L. (1989). Development and testing of a new measure of health status for clinical trials in heart failure. Journal of General Internal Medicine, 4(2), 101–107. doi:10.1007/BF02602348.
Harris, S., LeMaitre, J. P., Mackenzie, G., Fox, K. A., & Denvir, M. A. (2003). A randomised study of home-based electrical stimulation of the legs and conventional bicycle exercise training for patients with chronic heart failure. European Heart Journal, 24(9), 871–878. doi:10.1016/S0195-668X(02)00822-9.
Harrison, M. B., Browne, G. B., Roberts, J., Tugwell, P., Gafni, A., & Graham, I. D. (2002). Quality of life of individuals with heart failure: A randomized trial of the effectiveness of two models of hospital-to-home transition. Medical Care, 40(4), 271–282. doi:10.1097/00005650-200204000-00003.
Haykowsky, M., Vonder Muhll, I., Ezekowitz, J., & Armstrong, P. (2005). Supervised exercise training improves aerobic capacity and muscle strength in older women with heart failure. The Canadian Journal of Cardiology, 21(14), 1277–1280.
Hershberger, R. E., Nauman, D. J., Byrkit, J., Gillespie, G., Lackides, G., Toy, W., et al. (2005). Prospective evaluation of an outpatient heart failure disease management program designed for primary care: The Oregon model. Journal of Cardiac Failure, 11(4), 293–298. doi:10.1016/j.cardfail.2004.10.002.
Higgins, S. L., Hummel, J. D., Niazi, I. K., Giudici, M. C., Worley, S. J., Saxon, L. A., et al. (2003). Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. Journal of the American College of Cardiology, 42(8), 1454–1459. doi:10.1016/S0735-1097(03)01042-8.
Holst, D. P., Kaye, D., Richardson, M., Krum, H., Prior, D., Aggarwal, A., et al. (2001). Improved outcomes from a comprehensive management system for heart failure. European Journal of Heart Failure, 3(5), 619–625. doi:10.1016/S1388-9842(01)00164-7.
Keteyian, S. J., Brawner, C. A., Schairer, J. R., Levine, T. B., Levine, A. B., Rogers, F. J., et al. (1999). Effects of exercise training on chronotropic incompetence in patients with heart failure. American Heart Journal, 138(2 Pt 1), 233–240. doi:10.1016/S0002-8703(99)70106-7.
Kiès, P., Leclercq, C., Bleeker, G. B., Crocq, C., Molhoek, S. G., Poulain, C., et al. (2006). Cardiac resynchronisation therapy in chronic atrial fibrillation: Impact on left atrial size and reversal to sinus rhythm. Heart (British Cardiac Society), 92(4), 490–494. doi:10.1136/hrt.2005.064816. Epub 2005 Sep 13.
Klaus, L., Beniaminovitz, A., Choi, L., Greenfield, F., Whitworth, G. C., Oz, M. C., et al. (2000). Pilot study of guided imagery use in patients with severe heart failure. The American Journal of Cardiology, 86(1), 101–104. doi:10.1016/S0002-9149(00)00838-9.
Kuehneman, T., Saulsbury, D., Splett, P., & Chapman, D. B. (2002). Demonstrating the impact of nutrition intervention in a heart failure program. Journal of the American Dietetic Association, 102(12), 1790–1794. doi:10.1016/S0002-8223(02)90384-6.
Kukin, M. L., Kalman, J., Charney, R. H., Levy, D. K., Buchholz-Varley, C., Ocampo, O. N., et al. (1999). Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Circulation, 99(20), 2645–2651.
Laoutaris, I., Dritsas, A., Brown, M. D., Manginas, A., Alivizatos, P. A., & Cokkinos, D. V. (2004). Inspiratory muscle training using an incremental endurance test alleviates dyspnea and improves functional status in patients with chronic heart failure. European Journal of Cardiovascular Prevention and Rehabilitation, 11(6), 489–496. doi:10.1097/00149831-200412000-00008.
Lau, C. P., Yu, C. M., Chau, E., Fan, K., Tse, H. F., Lee, K., et al. (2000). Reversal of left ventricular remodeling by synchronous biventricular pacing in heart failure. Pacing and Clinical Electrophysiology, 23(11 Pt 2), 1722–1725.
Leclercq, C., Gras, D., Tang, A., Alonso, C., Thomas-Revault d’Allones, F., Mabo, P., et al. (2004). Comparative effects of ventricular resynchronization therapy in heart failure patients with or without coronary artery disease. Annales de Cardiologie et d’Angeiologie, 53(4), 171–176. doi:10.1016/j.ancard.2004.02.014.
Lee, D. T., Yu, D. S., & Woo, J. (2005). Validation of the chronic heart failure questionnaire (Chinese version). Quality of Life Research, 14(5), 1421–1426. doi:10.1007/s11136-004-4768-x.
Lenom, V., Materne, P., Hoffer, E., Lecoq, E., Désiron, Q., Waucquez, J. L., et al. (2005). Clinical value of cardiac resynchronization therapy in patients with congestive heart failure. Revue Medicale de Liege, 60(2), 101–108.
Levinger, I., Bronks, R., Cody, D. V., Linton, I., & Davie, A. (2005). Resistance training for chronic heart failure patients on beta blocker medications. International Journal of Cardiology, 102(3), 493–499. doi:10.1016/j.ijcard.2004.05.061. Epub 2004 Sep 23.
Linde, C., Leclercq, C., Rex, S., Garrigue, S., Lavergne, T., Cazeau, S., et al. (2002). Long-term benefits of biventricular pacing in congestive heart failure: Results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. Journal of the American College of Cardiology, 40(1), 111–118. doi:10.1016/S0735-1097(02)01932-0.
Little, W. C., Wesley-Farrington, D. J., Hoyle, J., Brucks, S., Robertson, S., Kitzman, D. W., et al. (2004). Effect of candesartan and verapamil on exercise tolerance in diastolic dysfunction. Journal of Cardiovascular Pharmacology, 43(2), 288–293. doi:10.1097/00005344-200402000-00019.
Livanis, E. G., Flevari, P., Theodorakis, G. N., Kolokathis, F., Leftheriotis, D., & Kremastinos, D. T. (2003). Effect of biventricular pacing on heart rate variability in patients with chronic heart failure. European Journal of Heart Failure, 5(2), 175–178. doi:10.1016/S1388-9842(02)00257-X.
Lupi, G., Brignole, M., Oddone, D., Bollini, R., Menozzi, C., & Bottoni, N. (2000). Effects of left ventricular pacing on cardiac performance and on quality of life in patients with drug refractory heart failure. American Journal of Cardiology, 86(11), 1267–70. A9.
McKelvie, R. S., Teo, K. K., Roberts, R., McCartney, N., Humen, D., Montague, T., et al. (2002). Effects of exercise training in patients with heart failure: The Exercise Rehabilitation Trial (EXERT). American Heart Journal, 144(1), 23–30. doi:10.1067/mhj.2002.123310.
Metra, M., Nardi, M., Giubbini, R., & Dei Cas, L. (1994). Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology, 24(7), 1678–1687.
Metra, M., Giubbini, R., Nodari, S., Boldi, E., Modena, M. G., & Dei Cas, L. (2000). Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation, 102(5), 546–551.
Meyer, K., Suter, C., & Laederach-Hofmann, K. (2002). Stress tolerance and quality of life—Effect of a comprehensive ambulatory rehabilitation program for patients with chronic heart failure. Schweizerische Rundschau fur Medizin Praxis, 91(38), 1531–1539.
Middel, B., Bouma, J., de Jongste, M., van Sonderen, E., Niemeijer, M. G., Crijns, H., et al. (2001). Psychometric properties of the Minnesota Living with Heart Failure Questionnaire (MLHF-Q). Clinical Rehabilitation, 15(5), 489–500. doi:10.1191/026921501680425216.
Miller, K., Myers, T. J., Robertson, K., Shah, N., Delgado, R. M., 3rd, & Gregoric, I. D. (2004). Quality of life in bridge-to-transplant patients with chronic heart failure after implantation of an axial flow ventricular assist device. Congestive Heart Failure (Greenwich, Conn.), 10(5), 226–229. doi:10.1111/j.1527-5299.2004.03258.x.
Molhoek, S. G., Bax, J. J., van Erven, L., Bootsma, M., Boersma, E., Steendijk, P., et al. (2002). Effectiveness of resynchronization therapy in patients with end-stage heart failure. The American Journal of Cardiology, 90(4), 379–383. doi:10.1016/S0002-9149(02)02493-1.
Molhoek, S. G., Bax, J. J., Bleeker, G. B., Holman, E. R., Van Erven, L., Bootsma, M., et al. (2005). Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failure. Journal of Cardiovascular Electrophysiology, 16(7), 701–707. doi:10.1111/j.1540-8167.2005.40685.x.
Ni, H., Toy, W., Burgess, D., Wise, K., Nauman, D. J., Crispell, K., et al. (2000). Comparative responsiveness of Short-Form 12 and Minnesota Living with Heart Failure Questionnaire in patients with heart failure. Journal of Cardiac Failure, 6(2), 83–91. doi:10.1054/jcaf.2000.7869.
O’Keeffe, S. T., Lye, M., Donnellan, C., & Carmichael, D. N. (1998). Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart (British Cardiac Society), 80(4), 377–382.
O’Leary, C. J., & Jones, P. W. (2000). The left ventricular dysfunction questionnaire (LVD-36): Reliability, validity, and responsiveness. Heart (British Cardiac Society), 83(6), 634–640. doi:10.1136/heart.83.6.634.
Ojeda, S., Anguita, M., Delgado, M., Atienza, F., Rus, C., Granados, A. L., et al. (2005). Short- and long-term results of a programme for the prevention of readmissions and mortality in patients with heart failure: Are effects maintained after stopping the programme? European Journal of Heart Failure, 7(5), 921–926. doi:10.1016/j.ejheart.2005.05.009.
Oka, R. K., De Marco, T., Haskell, W. L., Botvinick, E., Dae, M. W., Bolen, K., et al. (2000). Impact of a home-based walking and resistance training program on quality of life in patients with heart failure. The American Journal of Cardiology, 85(3), 365–369. doi:10.1016/S0002-9149(99)00748-1.
Parnell, M. M., Holst, D. P., & Kaye, D. M. (2002). Exercise training increases arterial compliance in patients with congestive heart failure. Clinical Science (London, England: 1979), 102(1), 1–7. doi:10.1042/CS20010107.
Pettersen, K. I., Reikvam, A., Rollag, A., & Stavem, K. (2005). Reliability and validity of the Kansas City cardiomyopathy questionnaire in patients with previous myocardial infarction. European Journal of Heart Failure, 7(2), 235–242. doi:10.1016/j.ejheart.2004.05.012.
Pollock, S. G., Lystash, J., Tedesco, C., Craddock, G., & Smucker, M. L. (1990). Usefulness of bucindolol in congestive heart failure. The American Journal of Cardiology, 66(5), 603–607. doi:10.1016/0002-9149(90)90488-M.
Prasun, M. A., Kocheril, A. G., Klass, P. H., Dunlap, S. H., & Piano, M. R. (2005). The effects of a sliding scale diuretic titration protocol in patients with heart failure. The Journal of Cardiovascular Nursing, 20(1), 62–70.
Quittan, M., Wiesinger, G. F., Crevenna, R., Nuhr, M. J., Posch, M., Hülsmann, M., et al. (2001). Cross-cultural adaptation of the Minnesota Living with Heart Failure Questionnaire for German-speaking patients. Journal of Rehabilitation Medicine, 33(4), 182–186.
Rector, T. S., Kubo, S. H., & Cohn, J. N. (1987). Patients’ self-assessment of their congestive heart failure. Part 2: Content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Failure, Oct/Nov: 198–209.
Rector, T. S., & Cohn, J. N. (1992). Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. American Heart Journal, 124(4), 1017–1025. doi:10.1016/0002-8703(92)90986-6.
Rector, T. S., Johnson, G., Dunkman, W. B., Daniels, G., Farrell, L., Henrick, A., et al. (1993). Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation, 87(6 Suppl), VI71–VI77.
Rich, M. W., Beckham, V., Wittenberg, C., Leven, C. L., Freedland, K. E., & Carney, R. M. (1995). A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. The New England Journal of Medicine, 333(18), 1190–1195. doi:10.1056/NEJM199511023331806.
Sanderson, J. E., Chan, S. K., Yu, C. M., Yeung, L. Y., Chan, W. M., Raymond, K., et al. (1998). Beta blockers in heart failure: A comparison of a vasodilating beta blocker with metoprolol. Heart (British Cardiac Society), 79(1), 86–92.
Sanderson, J. E., Chan, S. K., Yip, G., Yeung, L. Y., Chan, K. W., Raymond, K., et al. (1999). Beta-blockade in heart failure: A comparison of carvedilol with metoprolol. Journal of the American College of Cardiology, 34(5), 1522–1528. doi:10.1016/S0735-1097(99)00367-8.
Shively, M., Kodiath, M., Smith, T. L., Kelly, A., Bone, P., Fetterly, L., et al. (2005). Effect of behavioral management on quality of life in mild heart failure: A randomized controlled trial. Patient Education and Counseling, 58(1), 27–34. doi:10.1016/j.pec.2004.06.007.
Smart, N., Haluska, B., Jeffriess, L., & Marwick, T. H. (2005). Predictors of a sustained response to exercise training in patients with chronic heart failure: A telemonitoring study. American Heart Journal, 150(6), 1240–1247. doi:10.1016/j.ahj.2005.01.035.
Smith, L. E., Fabbri, S. A., Pai, R., Ferry, D., & Heywood, J. T. (1997). Symptomatic improvement and reduced hospitalization for patients attending a cardiomyopathy clinic. Clinical Cardiology, 20(11), 949–954.
Twidale, N., McDonald, T., Nave, K., & Seal, A. (1998). Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. Pacing and Clinical Electrophysiology, 21(4 Pt 1), 641–651. doi:10.1111/j.1540-8159.1998.tb00119.x.
van den Berg-Emons, R., Balk, A., Bussmann, H., & Stam, H. (2004). Does aerobic training lead to a more active lifestyle and improved quality of life in patients with chronic heart failure? European Journal of Heart Failure, 6(1), 95–100. doi:10.1016/j.ejheart.2003.10.005.
van den Broek, S. A., de Graeff, P. A., van Veldhuisen, D. J., van Gilst, W. H., Hillege, H., Wesseling, H., et al. (1997). Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failure. Journal of Cardiac Failure, 3(3), 165–171. doi:10.1016/S1071-9164(97)90012-9.
Varma, S., McElnay, J. C., Hughes, C. M., Passmore, A. P., & Varma, M. (1999). Pharmaceutical care of patients with congestive heart failure: Interventions and outcomes. Pharmacotherapy, 19(7), 860–869. doi:10.1592/phco.19.10.860.31565.
Vavouranakis, I., Lambrogiannakis, E., Markakis, G., Dermitzakis, A., Haroniti, Z., Ninidaki, C., et al. (2003). Effect of home-based intervention on hospital readmission and quality of life in middle-aged patients with severe congestive heart failure: A 12-month follow up study. European Journal of Cardiovascular Nursing, 2(2), 105–111. doi:10.1016/S1474-5151(03)00006-9.
Vizir, V. A., & Berezin, A. E. (2002). Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure. Terapevticheskii Arkhiv, 74(1), 52–55.
Warner, J. G., Jr., Metzger, D. C., Kitzman, D. W., Wesley, D. J., & Little, W. C. (1999). Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. Journal of the American College of Cardiology, 33(6), 1567–1572. doi:10.1016/S0735-1097(99)00048-0.
Wiklund, I., Lindvall, K., Swedberg, K., & Zupkis, R. V. (1987). Self-assessment of quality of life in severe heart failure. An instrument for clinical use. Scandinavian Journal of Psychology, 28(3), 220–225. doi:10.1111/j.1467-9450.1987.tb00758.x.
Wiklund, I., Waagstein, F., Swedberg, K., & Hjalmarsson, A. (1996). Quality of life on treatment with metoprolol in dilated cardiomyopathy: Results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial. Cardiovascular Drugs and Therapy, 10(3), 361–368.
Wilson, J. R., Groves, J., & Rayos, G. (1996). Circulatory status and response to cardiac rehabilitation in patients with heart failure. Circulation, 94(7), 1567–1572.
Witham, M. D., Gray, J. M., Argo, I. S., Johnston, D. W., Struthers, A. D., & McMurdo, M. E. (2005). Effect of a seated exercise program to improve physical function and health status in frail patients > or = 70 years of age with heart failure. The American Journal of Cardiology, 95(9), 1120–1124. doi:10.1016/j.amjcard.2005.01.031.
Wolinsky, F. D., Wyrwich, K. W., Nienaber, N. A., & Tierney, W. M. (1998). Generic versus disease-specific health status measures. An example using coronary artery disease and congestive heart failure patients. Evaluation & the Health Professions, 21(2), 216–243. doi:10.1177/016327879802100205.
Yeh, G. Y., Wood, M. J., Lorell, B. H., Stevenson, L. W., Eisenberg, D. M., Wayne, P. M., et al. (2004). Effects of tai chi mind–body movement therapy on functional status and exercise capacity in patients with chronic heart failure: A randomized controlled trial. The American Journal of Medicine, 117(8), 541–548. doi:10.1016/j.amjmed.2004.04.016.
Young, J. B., Abraham, W. T., Smith, A. L., Leon, A. R., Lieberman, R., Wilkoff, B., et al. (2003). Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. Journal of the American Medical Association, 289(20), 2685–2694. doi:10.1001/jama.289.20.2685.
Cowley, A. J., & Skene, A. M. (1994). Treatment of severe heart failure: Quantity or quality of life? A trial of enoximone. Enoximone Investigators. British Heart Journal, 72(3), 226–230. doi:10.1136/hrt.72.3.226.
Tamura, M., Omiya, K., Yamada, S., Oka, K., Suzuki, N., Osada, N., et al. (2003). Development of measure for disease-specific quality of life in patients with chronic heart failure. Journal of Cardiology, 42(4), 155–164.
U.S. Department of Health and Human Services, FDA Center for Drug Evaluation and Research. (2006). Guidance for industry. Patient-reported outcomes measures: Use in medical product development to support labeling claims: Draft guidance [online publication]. Available online at: http://www.fda.gov/cder/Guidance/5460dft.pdf.
Ferrer, M., Alonso, J., Morera, J., Marrades, R., Khalaf, A., Aguar, M. C., et al. (1997). Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Annals of Internal Medicine, 127(12), 1072–1079.
Lawrence, K., McWhinnie, D., Goodwin, A., Doll, H., Gordon, A., Gray, A., et al. (1995). Randomised controlled trial of laparoscopic versus open repair of inguinal hernia: Early results. BMJ (Clinical Research Ed.), 311, 981–985.
Bennett, L. S., Barbour, C., Langford, B., Stradling, J. R., & Davies, R. J. (1999). Health status in obstructive sleep apnea: relationship with sleep fragmentation and daytime sleepiness, and effects of continuous positive airway pressure treatment. American Journal of Respiratory and Critical Care Medicine, 159(6), 1884–1890.
Valderas, J. M., Ferrer, M., Mendívil, J., Garin, O., Rajmil, L., Herdman, M., et al. (2008). Development of EMPRO: A tool for the standardized assessment of patient-reported outcome measures. Value in Health (in press).
Acknowledgments
This study has been supported by the European Union (QLRI-CT-2000-00551), the CIRIT-Comisio Interdepartamental (2001 Sol·licitud Grups de Recerca 00405), and the Instituto de Salud Carlos III (SAF2002-11009-E). The authors are very grateful to the members of the IQOD Project, managed by the MAPI Research Institute. Furthermore, we would like to thank S Pérez and A Martin for general and editorial assistance in the preparation of this article; and R Elosua, M Cladellas, and J M Valderas for their clinical support.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Garin, O., Ferrer, M., Pont, À. et al. Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses. Qual Life Res 18, 71–85 (2009). https://doi.org/10.1007/s11136-008-9416-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-008-9416-4